UK will purchase the vaccine from COVID-19 development Sanofi GlaxoSmithKline 500 million pounds

Sanofi and GlaxoSmithKline entered into an agreement with the British government on the delivery of 60 million doses of vaccines against coronavirus 500 million pounds (625 million dollars). We are talking about the experimental vaccine, clinical trials which should begin in September of this year, writes Reuters.

It is expected that the successful completion of clinical trials, vaccine development, Sanofi and GlaxoSmithKline, will be registered in the beginning of next year. Currently, worldwide research is being conducted more than 100 candidate vaccines against coronavirus infection. While there is no approved method for the prevention of coronavirus, however, governments in many countries seek to ensure supplies of vaccines until it is registered, and to obtain performance data.

The agreement with Sanofi and GlaxoSmithKline was not the first for the British government. Earlier, an agreement was reached with Oxford-AstraZeneca about supply of 100 million doses of vaccine of its development.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]